Abstract:Background: Colon cancer (CC) is a highly prevalent malignancy worldwide, characterized by elevated mortality rates and poor prognosis. N7-methylguanosine (m7G) methylation is an emerging RNA modification type and involved in the development of many tumors. Despite this, the correlation between m7G-related miRNAs and CC remains to be elucidated. This research aimed to investigate the clinical significance of m7G-related miRNAs in predicting both the prognosis and tumor microenvironment (TME) of CC. Method: We retrieved transcriptome data and associated clinical information from a publicly accessible database. Using univariate Cox and LASSO regression analyses, we established a signature of m7G-related miRNAs. Additionally, we used CIBERSORT and ssGSEA algorithms to explore the association between the prognostic risk score and the TME in CC patients. By considering the risk signature and immune infiltration, we identified differentially expressed genes that contribute to the prognosis of CC. Finally, the expression patterns of prognostic miRNAs were verified using quantitative reverse transcriptase PCR (qRT-PCR) in cell lines. Results: We constructed a prognostic risk signature based on seven m7G-related miRNAs (miR-136-5p, miR-6887-3p, miR-195-5p, miR-149-3p, miR-4433a-5p, miR-31-5p, and miR-129-2-3p). Subsequently, we observed remarkable differences in patient outcomes between the high- and low-risk groups. The area under the curve (AUC) for 1-, 3-, and 5-year survivals in the ROC curve were 0.735, 0.707, and 0.632, respectively. Furthermore, our results showed that the risk score can serve as an independent prognostic biomarker for overall survival prediction. In terms of immune analysis, the results revealed a significant association between the risk signature and immune infiltration, as well as immune checkpoint expression. Finally, our study showed that CCDC160 and RLN3 is the gene most relevant to immune cells and function in CC. Conclusion: Our study conducted a comprehensive and systematic analysis of m7G-associated miRNAs to construct prognostic profiles of CC. We developed a prognostic risk model based on m7G-miRNAs, with the resulting risk scores demonstrating considerable potential as prognostic biomarkers. These findings provide substantial evidence for the critical role of m7G-related miRNAs in colon cancer and may offer new immunotherapeutic targets for patients with this disease.

Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

Associations Between Polymorphisms of Long Non-Coding Rna Meg3 and Risk of Colorectal Cancer in Chinese

Association of LncRNA MEG3 Polymorphisms with Efficacy of Neoadjuvant Chemotherapy in Breast Cancer

MEG3 rs7158663 genetic polymorphism is associated with the risk of hepatocellular carcinoma

Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival

Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients

Signature of micro RNA 146a/215 and IL-6/TGF-β levels in a cross-link axis between obesity and colorectal cancer

Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression

Downregulated Long Noncoding Rna Meg3 is Associated with Poor Prognosis and Promotes Cell Proliferation in Gastric Cancer

Prognostic Value of MEG3 and Its Correlation with Immune Infiltrates in Gliomas

Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer

Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and <i>KRAS </i>with colorectal cancer susceptibility and survival

Identification and analysis of key genes related to efferocytosis in colorectal cancer

Association of lncRNA EIF3J-AS1 with target gene IGFB3 polymorphisms in susceptibility of gastric cancer

A novel m7G-related miRNA prognostic signature for predicting clinical outcome and immune microenvironment in colon cancer

Harnessing the Supremacy of MEG3 LncRNA to Defeat Gastrointestinal Malignancies

Long non-coding RNA MEG3 functions as a competing endogenous RNA of miR-93 to regulate bladder cancer progression via PI3K/AKT/mTOR pathway

Impact of rs2107425 Polymorphism and Expression of lncH19 and miR-200a on the Susceptibility of Colorectal Cancer

Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia

A proteogenomic analysis of the adiposity colorectal cancer relationship identifies GREM1 as a probable mediator